RU2016144340A3 - - Google Patents

Download PDF

Info

Publication number
RU2016144340A3
RU2016144340A3 RU2016144340A RU2016144340A RU2016144340A3 RU 2016144340 A3 RU2016144340 A3 RU 2016144340A3 RU 2016144340 A RU2016144340 A RU 2016144340A RU 2016144340 A RU2016144340 A RU 2016144340A RU 2016144340 A3 RU2016144340 A3 RU 2016144340A3
Authority
RU
Russia
Application number
RU2016144340A
Other languages
Russian (ru)
Other versions
RU2698330C2 (ru
RU2016144340A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016144340A3 publication Critical patent/RU2016144340A3/ru
Publication of RU2016144340A publication Critical patent/RU2016144340A/ru
Application granted granted Critical
Publication of RU2698330C2 publication Critical patent/RU2698330C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
RU2016144340A 2014-04-21 2014-04-21 Быстрое купирование двигательных флуктуаций при болезни паркинсона RU2698330C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/034778 WO2015163840A1 (en) 2014-04-21 2014-04-21 Rapid relief of motor fluctuations in parkinson's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2019126085A Division RU2019126085A (ru) 2019-08-19 2019-08-19 Быстрое купирование двигательных флуктуаций при болезни паркинсона

Publications (3)

Publication Number Publication Date
RU2016144340A3 true RU2016144340A3 (enExample) 2018-05-22
RU2016144340A RU2016144340A (ru) 2018-05-22
RU2698330C2 RU2698330C2 (ru) 2019-08-26

Family

ID=54332876

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016144340A RU2698330C2 (ru) 2014-04-21 2014-04-21 Быстрое купирование двигательных флуктуаций при болезни паркинсона

Country Status (14)

Country Link
US (2) US20170296498A1 (enExample)
EP (2) EP3134077A4 (enExample)
JP (1) JP2017513866A (enExample)
KR (2) KR20210144946A (enExample)
CN (2) CN106659685B (enExample)
AU (2) AU2014391721B2 (enExample)
BR (1) BR112016024502A8 (enExample)
CA (1) CA2946165C (enExample)
IL (2) IL309959A (enExample)
MX (1) MX2016013741A (enExample)
RU (1) RU2698330C2 (enExample)
SG (1) SG11201608608PA (enExample)
WO (1) WO2015163840A1 (enExample)
ZA (1) ZA201607833B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014074797A1 (en) 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
BR112020013749A2 (pt) * 2018-01-05 2020-12-01 Impel Neuropharma, Inc. dispensação intranasal de pó de levodopa por dispositivo olfativo de precisão
US11517548B2 (en) 2018-07-19 2022-12-06 Impel Pharmaceuticals Inc. Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US6858199B1 (en) 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
HUE031167T2 (hu) * 2002-03-20 2017-07-28 Civitas Therapeutics Inc A levodopa pulmonális bejuttatása
AR044007A1 (es) * 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
US8496002B2 (en) 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
GB2454480A (en) * 2007-11-07 2009-05-13 Vectura Group Plc Pulmonary inhalation of levodopa containing compositions in the treatment of Parkinsons disease and other central nervous system disorders
AU2009265760B2 (en) * 2008-06-30 2013-07-18 Novartis Ag Combinations comprising mGluR modulators for the treatment of parkinson's disease
US8399513B2 (en) * 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
TW201304822A (zh) * 2010-11-15 2013-02-01 Vectura Ltd 組成物及用途
MX390106B (es) * 2012-10-22 2025-03-20 Merz Pharmaceuticals Llc Formulaciones de levodopa para el alivio rapido de la enfermedad de parkinson
US8545878B1 (en) * 2012-11-09 2013-10-01 Civitas Therapeutics, Inc. Capsules containing high doses of levodopa for pulmonary use

Also Published As

Publication number Publication date
US20170296498A1 (en) 2017-10-19
RU2698330C2 (ru) 2019-08-26
US20230053976A1 (en) 2023-02-23
CA2946165C (en) 2022-10-18
AU2020239754B2 (en) 2022-06-23
JP2017513866A (ja) 2017-06-01
KR20170008754A (ko) 2017-01-24
EP3134077A1 (en) 2017-03-01
EP3831375A1 (en) 2021-06-09
KR20210144946A (ko) 2021-11-30
BR112016024502A8 (pt) 2021-06-29
EP3134077A4 (en) 2017-12-20
MX2016013741A (es) 2017-04-06
AU2014391721B2 (en) 2020-07-16
SG11201608608PA (en) 2016-11-29
CA2946165A1 (en) 2015-10-29
ZA201607833B (en) 2018-08-29
CN113209055A (zh) 2021-08-06
RU2016144340A (ru) 2018-05-22
IL309959A (en) 2024-03-01
AU2014391721A1 (en) 2016-11-03
CN106659685B (zh) 2021-02-05
WO2015163840A1 (en) 2015-10-29
AU2020239754A1 (en) 2021-01-14
IL248445A0 (en) 2016-12-29
BR112016024502A2 (pt) 2017-08-15
CN106659685A (zh) 2017-05-10

Similar Documents

Publication Publication Date Title
BR112016017578A2 (enExample)
BR112016018088A2 (enExample)
BR112016016195A2 (enExample)
BR112016016602A2 (enExample)
BR112016017950A2 (enExample)
BR112016018369A2 (enExample)
BR112016016127A2 (enExample)
BR112016017899A2 (enExample)
BR112016017262A2 (enExample)
BR112016017660A2 (enExample)
BR112016015479A2 (enExample)
BR112016017960A2 (enExample)
BR112016015542A2 (enExample)
BR112016016863A2 (enExample)
BR112016016389A2 (enExample)
BR112016017693A2 (enExample)
BR112016015963A2 (enExample)
BR112016015907A2 (enExample)
BR112016015293A2 (enExample)
BR112016017221A2 (enExample)
BR112016015619A2 (enExample)
BR112016017018A2 (enExample)
BR112016017752A2 (enExample)
BR112016015154A2 (enExample)
BR112016016529A2 (enExample)